AbCellera Biologics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2024 | — | $1.13B | $123.6M |
| Jun 2024 | — | $1.11B | $148.3M |
| Sep 2024 | — | $1.08B | $126.6M |
| Dec 2024 | — | $1.06B | $156.3M |
| Mar 2025 | — | $1.02B | $159.3M |
| Jun 2025 | — | $1.01B | $92.4M |
| Sep 2025 | — | $964.0M | $83.2M |
| Dec 2025 | — | $966.9M | $128.5M |
| Mar 2026 | — | $938.1M | $77.1M |
| Jun 2026 | — | $896.0M | $120.1M |